These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6455809)

  • 41. Allogeneic kidney cells stimulate the production of immunoregulatory cytokines in mixed kidney lymphocyte culture.
    Takahara S; Moutabarrik A; Namiki M; Yamaguchi S; Kameoka H; Ishibashi M; Zaid D; Okuyama A
    Transplant Proc; 1993 Jun; 25(3):2314. PubMed ID: 8516912
    [No Abstract]   [Full Text] [Related]  

  • 42. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
    Lordon RE; Wilson RL; Shield CF; Ferrone S
    Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of kidney-specific peptides and their role in renal allograft rejection.
    Poindexter NJ; Naziruddin B; Oppat W; Flye MW; Mohanakumar T
    Transplant Proc; 1995 Feb; 27(1):900-2. PubMed ID: 7879223
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term (24-month) follow-up of steroid withdrawal in renal allograft recipients with posttransplant diabetes mellitus.
    Fabrega AJ; Meslar P; Cohan J; Lash J; Pollak R
    Transplantation; 1995 Dec; 60(12):1612-4. PubMed ID: 8545899
    [No Abstract]   [Full Text] [Related]  

  • 46. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients.
    Tufveson G; Odlind B; Sjöberg O; Lindberg A; Gabrielsson J; Lindström B; Lithell H; Selinus I; Tötterman T; Wahlberg J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):16-24. PubMed ID: 2947364
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
    Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.
    Baeten D; Louis S; Braud C; Braudeau C; Ballet C; Moizant F; Pallier A; Giral M; Brouard S; Soulillou JP
    J Am Soc Nephrol; 2006 Jan; 17(1):294-304. PubMed ID: 16338967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients.
    Stock PG; Lantz M; Light S; Vincenti F
    Transplant Proc; 1996 Apr; 28(2):915-6. PubMed ID: 8623460
    [No Abstract]   [Full Text] [Related]  

  • 51. Cimetidine does not stimulate human T lymphocyte functions in vitro.
    Charpentier B; Lang P; Martin B; Fries D
    Biomed Pharmacother; 1982; 36(5):250-4. PubMed ID: 6984826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low level of interleukin 10 synthesis during liver allograft rejection.
    Conti F; Boulland ML; Leroy-Viard K; Chereau C; Dousset B; Soubrane O; Weill B; Calmus Y
    Lab Invest; 1998 Oct; 78(10):1281-9. PubMed ID: 9800954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro donor-specific hyporesponsiveness and T cell subsets in renal allograft recipients.
    Bas J; Mestre M; Griñó JM; Massip E; Castelao AM; Romeu A; González L; Valls A; Buendía E
    Allergol Immunopathol (Madr); 1993; 21(4):136-40. PubMed ID: 8237717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD45 isoforms and lymphocyte activation antigens in acute renal allograft rejection.
    Battochio A; Solez K; Poppema S; Cockfield S; Rayner D
    Transplant Proc; 1996 Feb; 28(1):482-3. PubMed ID: 8644320
    [No Abstract]   [Full Text] [Related]  

  • 55. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
    Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
    Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection.
    Rouschop KM; Roelofs JJ; Rowshani AT; Leemans JC; van der Poll T; Ten Berge IJ; Weening JJ; Florquin S
    Nephrol Dial Transplant; 2005 Oct; 20(10):2248-54. PubMed ID: 16166750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Xenogenic mixed lymphocyte culture as a model for studying the mechanism of the pathogenesis of graft rejection].
    Polunin AI; Alekseev LP
    Patol Fiziol Eksp Ter; 1978; (4):46-50. PubMed ID: 151849
    [No Abstract]   [Full Text] [Related]  

  • 59. [In vitro behavior in culture of lymphocytes from nephropathic and diabetic patients].
    Lanza C; Lazzaro C; Spampinato F
    Riv Anat Patol Oncol; 1968; 33():XXVII+. PubMed ID: 5760194
    [No Abstract]   [Full Text] [Related]  

  • 60. Urinary enzymes as indices of graft function in renal transplant recipients taking cimetidine.
    Krishna KS; Kirubakaran MG; Kanagasabapathy AS
    Clin Chem; 1986 Jan; 32(1 Pt 1):201. PubMed ID: 2866854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.